ZW Data Action Technologies Inc. (CNET): Nasdaq/NYSE listing notice — ZW Data Action Technologies receives Nasdaq deficiency notice for bid price below $1

ZW Data Action Technologies Inc.

Received Nasdaq deficiency letter on Nov 1, 2023 for bid price closing below $1 for 30 consecutive business days.
Has 180 calendar days (until April 29, 2024) to regain compliance with Minimum Bid Price Requirement.
If compliance not achieved, may be eligible for a second 180-day period if meeting other listing standards and intent to cure via reverse stock split.
Company will monitor and evaluate options but cannot assure compliance with Nasdaq listing standards.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ZW Data Action Technologies Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

November 1, 2023, ZW Data Action Technologies Inc., a Nevada corporation (the “Company”) received a notice in the form of a letter (“Deficiency Letter”) from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the bid price for the Company’s common stock had closed below $1.00 per share for the previous 30 consecutive business days (the “Minimum Bid Price Requirement”). The Nasdaq Deficiency Letter has no immediate effect on the listing of the Company’s co

View on SEC.gov

6 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ZW Data Action Technologies Inc. filing history →

Source: SEC EDGAR

accession 0001171843-23-006670

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.